Appointed Program Director of the Global Internship in Computational Drug Design

BioLink Therapeutics, INDIA is proud to welcome Dr. Katharine H. Cole as an Independent Director and the newly appointed Program Director of its prestigious Global Industrial Internship Program in Computational Drug Design—an advanced training initiative for bachelor’s and master’s students aiming to lead innovation in pharmaceutical R&D.

With a distinguished career that bridges cutting-edge biomedical research, academic leadership, and global education strategy, Dr. Cole will bring unparalleled expertise and vision to this program.

👩‍🔬 About Dr. Katharine H. Cole

Dr. Cole is an accomplished scientist, educator, and senior university administrator, whose career includes leadership and faculty roles at some of the USA’s top institutions:

• Vice Provost and Dean Emerita, University of Maryland, Baltimore County (UMBC)
• Former Associate Provost and Dean of Academic Services, University of Tampa
• Former Associate Dean of Undergraduate Studies, University of South Florida (USF)
• Former Faculty Member, University of Maryland School of Medicine, University of South Florida, and University of Tampa
• Postdoctoral Research Fellow, National Cancer Institute (NCI), National Institutes of Health (NIH)

While Dr. Cole held faculty appointments at all these institutions, she actively taught courses at the University of Maryland School of Medicine and the University of South Florida, combining her scientific expertise with a commitment to student learning.

She earned her Ph.D. in Pathology from the University of Maryland School of Medicine and completed postdoctoral training at the National Cancer Institute, NIH. Her research has focused on cell cycle regulation and cellular differentiation in the malignant transformation of human lung and liver cells.

During her 12 years as Vice Provost and Dean, Dr. Cole oversaw multiple academic departments, guided curricular innovation, advanced high-impact educational practices, and developed strategic initiatives to prepare students for professional success. She also has extensive expertise in regional and programmatic accreditation, internship-to-credit conversions, transfer credit evaluation, and course articulation agreements.

“Dr. Cole’s leadership and scientific expertise will help establish BioLink’s internship program as a global benchmark for computational drug discovery training,” says Dr. Biswarup Ghosh, Co-CEO at BioLink Therapeutics.

🌍 The Global Internship Program: Training Tomorrow’s Drug Discovery Leaders

Under Dr. Cole’s direction, the BioLink Global Internship Program will provide students with:

• 🔬 Hands-on training in AI-driven drug discovery and computational chemistry
• 💻 Practical experience in molecular docking, virtual screening, and ADMET prediction
• 🌐 Mentorship from global academic and industry experts
• 🎓 Certification, networking opportunities, and career guidance

This program is built for students who want real-world, industry-aligned research experience at the intersection of biotechnology, artificial intelligence, and medicinal chemistry.

🗣️ “I’m excited to join BioLink Therapeutics and lead this initiative,” says Dr. Cole. “Together, we will empower students with advanced scientific training and global collaboration opportunities.”

📅 Applications Open Soon | 🌐 Available to Students Worldwide
🎯 Seats Limited — Selection Based on Academic Merit & Passion for Science, Send us your interest through message below.